- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01078337
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
March 1, 2010 updated by: Stanford University
T-cell MRD Evaluation Using Flow Cytometric Analysis
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
children with newly diagnosed T-cell ALL
Description
Inclusion Criteria:
- Children with newly diagnosed T-cell ALL
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gary V Dahl, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2002
Primary Completion (ACTUAL)
October 1, 2007
Study Completion (ACTUAL)
October 1, 2007
Study Registration Dates
First Submitted
February 26, 2010
First Submitted That Met QC Criteria
March 1, 2010
First Posted (ESTIMATE)
March 2, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 2, 2010
Last Update Submitted That Met QC Criteria
March 1, 2010
Last Verified
February 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-11022007-790
- PEDSALL0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Leukemia, Lymphocytic, Acute
-
Eastern Cooperative Oncology GroupCompletedAdult Patients (Over 55) With Acute Non-Lymphocytic Leukemia
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
Daiichi Sankyo, Inc.TerminatedLeukemia, Myeloid, Acute | Leukemia, Lymphocytic, AcuteUnited States
-
University of MinnesotaChildren's Cancer Research Fund United StatesTerminatedLymphoblastic Lymphoma | Brain Tumors | Lymphoblastic Leukemia, Acute, Childhood | Lymphoblastic Leukemia | Leukemia, Lymphocytic, Acute | Leukemia, Lymphoblastic, Acute | Brain Neoplasms, Malignant | ALL, Childhood | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Lymphoblastic Leukemia, Acute | Leukemia... and other conditionsUnited States
-
Genzyme, a Sanofi CompanyCompletedSolid Tumors | Leukemia, Myelocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Adult | Leukemia, Myelocytic, Acute, Adult | Myelodysplastic Syndromes, AdultUnited States
-
First Affiliated Hospital of Wenzhou Medical UniversitySecond Affiliated Hospital of Nanchang University; Hrain Biotechnology Co.,...UnknownHematopoietic/Lymphoid Cancer | Adult Acute Lymphoblastic Leukemia in Remission | B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | B-cell Adult Acute Lymphoblastic LeukemiaChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia (AML) | Acute Lymphocytic Leukemia (ALL) | Acute Promyelocytic Leukemia (APL)United States
-
Goethe UniversityCompletedAdult Acute Lymphocytic LeukemiaGermany
-
Shanxi Province Cancer HospitalShanghai Ultra-T Immune Therapeutics Co. LTDRecruitingAcute Lymphocytic Leukemia, B-CellChina
-
Proacta, IncorporatedUnknownAcute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
Clinical Trials on bone marrow aspiration
-
Clinical Center of Cellular Technologies, RussiaSamara State Medical University; Regional hospital of SamaraCompletedLower Extremity Ischemia
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineCompleted
-
University Hospital HeidelbergGerman Cancer Research Center; Heidelberg UniversityActive, not recruiting
-
Alexandra Cristina SenegagliaPontifícia Universidade Católica do Paraná; Fundação Araucária; Consultório Médico... and other collaboratorsCompleted
-
Stanford UniversityTerminated
-
Andrews Research & Education FoundationFloridaRecruitingRotator Cuff Tear or Rupture, Not Specified as TraumaticUnited States
-
Vidacare CorporationCompletedBone Marrow Aspiration and Biopsy Specimen CollectionUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
Institut Paoli-CalmettesCompleted